Related references
Note: Only part of the references are listed.Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survival
S. V. Ward et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Photoprotective Properties of Vitamin D and Lumisterol Hydroxyderivatives
Andrzej T. Slominski et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2020)
Associations of Circulating 25-Hydroxyvitamin D3 Concentrations With Incident, Sporadic Colorectal Adenoma Risk According to Common Vitamin D-Binding Protein Isoforms
David C. Gibbs et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2018)
Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management
Andrzej T. Slominski et al.
LABORATORY INVESTIGATION (2017)
Melanoma in Hispanic and Black Americans
Panta Rouhani et al.
Cancer Control (2017)
Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas
D. C. Gibbs et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants
Mitchell J. Machiela et al.
BIOINFORMATICS (2015)
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma
Matthew H. Law et al.
NATURE GENETICS (2015)
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma
Nancy E. Thomas et al.
JAMA ONCOLOGY (2015)
Associations between Vitamin D-Binding Protein Isotypes, Circulating 25(OH)D Levels, and Vitamin D Metabolite Uptake in Colon Cancer Cells
Elizabeth A. Hibler et al.
CANCER PREVENTION RESEARCH (2014)
Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: A comprehensive review and meta-analysis
Saverio Caini et al.
EUROPEAN JOURNAL OF CANCER (2014)
An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study
John R. Davies et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
The role of vitamin D in reducing cancer risk and progression
David Feldman et al.
NATURE REVIEWS CANCER (2014)
Common variants of the vitamin D binding protein gene and adverse health outcomes
Suneil Malik et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2013)
Expression of the vitaimin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression
Anna A. Brozyna et al.
HUMAN PATHOLOGY (2013)
Tumor-Infiltrating Lymphocyte Grade in Primary Melanomas Is Independently Associated With Melanoma-Specific Survival in the Population-Based Genes, Environment and Melanoma Study
Nancy E. Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
In vivo evidence for a novel pathway of vitamin D3 metabolism initiated by P450scc and modified by CYP27B1
Andrzej T. Slominski et al.
FASEB JOURNAL (2012)
Vitamin D receptor polymorphisms in patients with cutaneous melanoma
Irene Orlow et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The Western Australian Melanoma Health Study: Study design and participant characteristics
Sarah V. Ward et al.
CANCER EPIDEMIOLOGY (2011)
Vitamin D Binding Protein-Macrophage Activating Factor Directly Inhibits Proliferation, Migration, and uPAR Expression of Prostate Cancer Cells
Kalvin J. Gregory et al.
PLOS ONE (2010)
Serum 25-Hydroxyvitamin D3 Levels Are Associated With Breslow Thickness at Presentation and Survival From Melanoma
Julia A. Newton-Bishop et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status
Sascha Abbas et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma
Colin B. Begg et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2006)
Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): A cross-sectional study on 595 - Early postmenopausal women
AL Lauridsen et al.
CALCIFIED TISSUE INTERNATIONAL (2005)
Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice
O Kisker et al.
NEOPLASIA (2003)
Share Paper
